Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Biogen
BIIB
$31.1B
| $51.3M | 0.03% |
160,964
-502,732
| -76% | -$161M |
|
577
Wheaton Precious Metals
WPM
$59.9B
| $51.2M | 0.03% |
2,312,515
+1,209,920
| +110% | +$25.2M |
|
578
American International
AIG
$39.8B
| $51.1M | 0.03% |
858,186
+581,749
| +210% | +$35.7M |
|
|
P
579
Everpure Inc
P
$39B
| $51.1M | 0.03% |
3,223,384
+935,050
| +41% | +$15.6M |
|
580
Motorola Solutions
MSI
$77B
| $50.9M | 0.03% |
563,318
-168,036
| -23% | -$15.3M |
|
581
Spectrum Brands
SPB
$2.09B
| $50.8M | 0.03% |
451,857
-412,429
| -48% | -$45.1M |
|
|
TMX
582
DELISTED
Terminix Global Holdings, Inc.
TMX
| $50.8M | 0.03% |
1,478,036
-831,808
| -36% | -$26.8M |
|
583
CALL
Teva Pharmaceuticals
TEVA
$42.6B
| $50.7M | 0.03% |
2,673,800
+1,186,600
| +80% | +$17.9M |
|
|
HPP
584
Hudson Pacific Properties
HPP
$787M
| $50.6M | 0.03% |
211,025
-157,054
| -43% | -$37.7M |
|
|
X
585
CALL
DELISTED
US Steel
X
| $50.3M | 0.03% |
1,429,600
-608,900
| -30% | -$17.7M |
|
586
Ulta Beauty
ULTA
$22.2B
| $50.3M | 0.03% |
224,803
+32,649
| +17% | +$6.91M |
|
587
Canadian Natural Resources
CNQ
$98.1B
| $50.2M | 0.03% |
2,863,995
+1,791,920
| +167% | +$30.1M |
|
|
RDS.A
588
CALL
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $50.2M | 0.03% |
752,000
+466,100
| +163% | +$29.4M |
|
589
Hyatt Hotels
H
$16.9B
| $50.1M | 0.03% |
681,103
-201,331
| -23% | -$13.6M |
|
|
DCH
590
Dauch Corp
DCH
$1.6B
| $50.1M | 0.03% |
2,940,608
+532,693
| +22% | +$9.43M |
|
591
AnaptysBio
ANAB
$1.66B
| $50M | 0.03% |
496,769
-87,080
| -15% | -$6.41M |
|
|
EA
592
CALL
DELISTED
Electronic Arts
EA
| $50M | 0.03% |
475,800
+268,400
| +129% | +$29.8M |
|
|
IPHI
593
DELISTED
INPHI CORPORATION
IPHI
| $50M | 0.03% |
1,365,549
-29,074
| -2% | -$1.14M |
|
594
iShares 20+ Year Treasury Bond ETF
TLT
$40.8B
| $49.9M | 0.03% |
393,178
+132,870
| +51% | +$16.7M |
|
595
Lamb Weston
LW
$7.39B
| $49.7M | 0.03% |
881,077
+163,515
| +23% | +$8.62M |
|
596
PUT
Philip Morris
PM
$294B
| $49.7M | 0.03% |
470,000
+67,000
| +17% | +$7.14M |
|
597
Chipotle Mexican Grill
CMG
$41.3B
| $49.6M | 0.03% |
8,588,900
+5,596,800
| +187% | +$33.4M |
|
598
Patterson-UTI
PTEN
$4.16B
| $49.6M | 0.03% |
2,157,523
-3,224,148
| -60% | -$66.8M |
|
599
Verisk Analytics
VRSK
$24.2B
| $49.6M | 0.03% |
516,995
+377,541
| +271% | +$34.2M |
|
600
Apple
AAPL
$4.46T
| $49.5M | 0.03% |
1,170,632
-720,992
| -38% | -$30.1M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.